Several drinking water recalls are ongoing as the U.S. Food and Drug Administration (FDA) set the risk level for a brand that ...

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...

CEO David Ricks said the sale of cheaper, off-brand versions of the company’s blockbuster weight loss drug isn’t having a ...

The telehealth firm said it would share the information with the U.S. Food and Drug Administration about shortages of the brand-name treatments, it said ... CONTEXT The FDA took Lilly's Zepbound off ...

When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market, but that process can take a while.

The products are part of the agency's ongoing public health alert concerning cinnamon with elevated lead levels ...

Simbe Brand Insights is available to vendor teams through Simbe Mobile, which streamlines work by putting a near real-time, ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.